Sequent Scientific Limited SEQUENT.NS · Stock Open Sequent Scientific Limited in new tab
Sequent Scientific Limited Analysis (SEQUENT.NS)
Is Sequent Scientific Limited a good investment? Sequent Scientific Limited (SEQUENT.NS) is currently trading at 202.40 INR.
In terms of valuation, the stock trades at a P/E ratio of 123.42. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Sequent Scientific Limited is expected to release its next earnings report on Feb. 9, 2026. The market consensus estimate for Forward EPS is 5.05.
Investor FAQ
Does Sequent Scientific Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Sequent Scientific Limited?
Sequent Scientific Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Feb. 9, 2026. The company currently has a trailing EPS of 1.63.
Company Profile
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
| Year | Total Dividends |
|---|---|
| ▸2021 |
0.50 INR
|
| Oct. 21, 2021 | 0.5000 |
| ▸2019 |
0.20 INR
|
| Sept. 28, 2019 | 0.2000 |
| ▸2017 |
0.20 INR
|
| Dec. 4, 2017 | 0.2000 |
Community Discussion